Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 2, 2006, Pages 169-172

  Atabek, Mehmet Emre ^a   Pirgon, Ozgur ^a   Sert, Ahmet ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Infant; Oral alendronate therapy; Vitamin D intoxication

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; CALCIUM; CORTICOSTEROID; DIURETIC AGENT; FUROSEMIDE; PREDNISONE; VITAMIN D;

ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CHILD CARE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG INDICATION; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HYDRATION; HYPERCALCEMIA; INFANT; KIDNEY CALCIFICATION; LABORATORY TEST; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRESCRIPTION; RICKETS; SEPSIS; TREATMENT OUTCOME; VITAMIN D INTOXICATION;

EID: 33644747219     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.2.169     Document Type: Article

References (12)

1. Streck WF, Waterhouse C, Haddad JG. Glucocorticoid effects in vitamin D intoxication. Arch Intern Med 1979; 139: 974-977.
2. Lteif AN, Zimmerman D. Biphosphonates for treatment of childhood hypercalcemia. Pediatrics 1988; 102: 990-993.
3. Genuth SM. Endocrine regulation of the metabolism of calcium and phosphate. In: Berne RM, Levy MN, eds. Principles of Physiology, 3rd Ed. St. Louis, MO: Mosby, 2000; 519-532.
4. Marcus R. Agents affecting calcification and bone turnover. In: Handman JG, Limbind LE, Molinoff PB, et al., eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th Ed. New York: McGraw-Hill, 1996; 1519-1546.
5. Sjoden G, Lindgren U. The effect of prednisolone on kidney calcification in vitamin D treated rats. Calcif Tissue Int 1985; 37: 613-616
6. Kleinschmidt KC, Delaney KA. Fluids and electrolytes. In: Ford MD, Delaney KA, Ling LJ, et al., eds. Clinical Toxicology, 1st Ed. Philadelphia, PA: WB Saunders, 2001; 79-91.
7. Rauch F, Travers R, Plotkin H, Glorieux FH. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 2002; 110: 1293-1299.
8. Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr 2003; 11: 735-751.
9. Lindsay R. Modeling the benefits of pamidronate in children with osteogenesis imperfecta. J Clin Invest 2002; 110: 1239-1241.
10. Plotkin H, Rauch F, Bishop NJ, Montpetit K, Ruck-Gibbs J, Travers R, Glorieux FH. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 2000; 85: 1846-1850.
11. Kerdudo C, Aerts I, Fattet S, Chevret L, Pacquement H, Doz F, Michon J, Garabedian M, Orbach D. Hypercalcemia and childhood cancer: a 7-year experience. J Pediatr Hematol Oncol 2005; 27: 23-27.
12. Von Muhlendahl KE, Nawracala J. Vitamin D intoxication. Eur J Pediatr 1999; 158: 266.